Access Resources
1591 - 1600 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Brain health: The hidden casualty of a humanitarian crisisJournal Name: The Lancet Regional Health - EuropePublisher: Elsevier BVVol: 15Issue #:Start Page: 100374End Page: 100374Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100374Best OA location URL: https://doi.org/10.1016/j.lanepe.2022.100374Citation Count: 4
-
RESTRICTEDTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://europepmc.org/articles/pmc8985079?pdf=renderCitation Count: 68
- Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study2022RESTRICTEDTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 6
- Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial2022RESTRICTEDTitle: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD TrialJournal Name: Genomics, Proteomics & BioinformaticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 2Start Page: 274End Page: 287Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009Best OA location URL: https://doi.org/10.1016/j.gpb.2021.08.009Citation Count: 23
-
RESTRICTEDTitle: Functional tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120208End Page: 120208Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2022.120208Best OA location URL: http://www.jns-journal.com/article/S0022510X22000703/pdfCitation Count: 8
- Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology2022RESTRICTEDTitle: Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technologyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120197End Page: 120197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120197Best OA location URL: http://www.jns-journal.com/article/S0022510X22000594/pdfCitation Count: 10
-
RESTRICTEDTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 3
- La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles2022RESTRICTEDTitle: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnellesJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152Citation Count: 0
-
RESTRICTEDTitle: Levodopa-induced dyskinesia: a brief review of the ongoing clinical trialsJournal Name: Neurodegenerative Disease ManagementPublisher: Future Medicine LtdVol: 12Issue #: 2Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0051Citation Count: 3
-
RESTRICTEDTitle: Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagyJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 1501End Page: 1513Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2022.03.012Best OA location URL: http://www.cell.com/article/S1097276522002210/pdfCitation Count: 44